Survivin: A promising tumor biomarker
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Cancer Letters
- Vol. 249 (1) , 49-60
- https://doi.org/10.1016/j.canlet.2006.12.020
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Differential expression of survivin-2B and survivin-ΔEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)Lung Cancer, 2005
- Survivin splice variants regulate the balance between proliferation and cell deathOncogene, 2005
- Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell DeathThe Journal of Experimental Medicine, 2004
- Survivin, versatile modulation of cell division and apoptosis in cancerOncogene, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- Differential subcellular localization of functionally divergent survivin splice variantsCell Death & Differentiation, 2002
- Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomasInternational Journal of Cancer, 2002
- CRM1-Mediated Nuclear Export Determines the Cytoplasmic Localization of the Antiapoptotic Protein SurvivinExperimental Cell Research, 2002
- Clinical Uses of Tumor Markers: A Critical ReviewCritical Reviews in Clinical Laboratory Sciences, 2001
- Marked Induction of the IAP Family Antiapoptotic Proteins Survivin and XIAP by VEGF in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999